Tower Research Capital LLC (TRC) - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 37 filers reported holding THE ONCOLOGY INSTITUTE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q2 2023$2,002
+19920.0%
3,640
-75.2%
0.00%
Q1 2023$10
-16.7%
14,681
+109.1%
0.00%
Q4 2022$12
-99.8%
7,021
+318.9%
0.00%
Q3 2022$8,000
-57.9%
1,676
-54.6%
0.00%
Q2 2022$19,000
+216.7%
3,688
+352.5%
0.00%
Q1 2022$6,000
+200.0%
815
+307.5%
0.00%
Q4 2021$2,0002000.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Parian Global Management LP 183,828$930,0004.26%
Velan Capital Investment Management LP 600,000$3,036,0003.08%
Triatomic Management LP 365,679$1,850,0001.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,383,099$17,118,0000.35%
Redmile Group, LLC 1,736,116$8,785,0000.34%
Saba Capital Management, L.P. 367,292$1,858,0000.02%
FMR LLC 12,000,078$60,720,0000.01%
BANK OF AMERICA CORP /DE/ 6,251$31,0000.00%
WELLS FARGO & COMPANY/MN 470$2,0000.00%
NORTHERN TRUST CORP 143,921$729,0000.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders